Home > Insider Trading > Filing (0001127602-18-029362)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1580827	C Eva Boratto	One Cvs Drive Woonsocket RI 02895	Evp, Cont & Chief Acct Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-01	4,426	$54.53	46,277	No	4	M	Direct
Common Stock	Disposition	2018-10-01	4,426	$80.00	41,851	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2018-10-01	4,426	$0.00	4,426	$54.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,852	2014-04-01	2020-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	12,212	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$74.29	2015-04-01	2021-04-01	18,882	18,882	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	27,392	27,392	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	21,509	21,509	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	35,062	35,062	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	35,030	35,030	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-01	18,882	18,882	Direct
2022-04-01	27,392	27,392	Direct
2023-04-01	21,509	21,509	Direct
2024-04-03	35,062	35,062	Direct
2025-04-01	35,030	35,030	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Option became exercisable in four equal annual installments, commencing 4/1/2014.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option becomes exercisable in four equal annual installments, commencing 4/1/2019.